Developing new cancer prevention and treatment strategies through clinical trials
Official title: Advancing novel cancer preventive and therapeutic strategies across the modern NCI clinical trial networks
Funded at University of California-Irvine · NIH-10781770 · Data updated 2026-11-12
This study is all about making cancer research better by including more diverse groups of people, so that everyone can benefit from the findings and help reduce health differences among communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project start | September 4, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $196,267 |
| NIH project number | 1R50CA285412-01 |
| Project ID | NIH-10781770 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals from racially and ethnically diverse backgrounds who are at risk for or affected by cancer.
✕Less likely to help
Patients who do not belong to underrepresented racial or ethnic groups may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing cancer prevention and treatment by improving diversity in clinical trials. It aims to reduce health disparities by promoting the inclusion of underrepresented populations in cancer research. The project will leverage existing collaborations and innovative recruitment strategies to ensure a diverse participant pool, which is crucial for generating meaningful data. The Principal Investigator, with extensive experience in clinical trial networks, will lead efforts to submit novel research concepts and ensure rigorous review processes.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer prevention and treatment strategies that are inclusive of diverse populations.
How similar studies have gone: Previous research has shown success in improving clinical trial outcomes by enhancing diversity, making this approach both promising and tested.
Where this research is happening
-
University of California-Irvine
Irvine, United States Active
Researchers
- Principal investigator: Zell, Jason — University of California-Irvine
- Study coordinator: Zell, Jason
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.